The clinical approach to child and adolescent patients with lipodystrophy: a series of international case discussions
Lipodystrophy syndromes comprise a group of rare endocrine disorders characterized by the generalized or partial loss of adipose tissue. Affected individuals frequently display absolute or relative reductions in leptin, a key adipokine regulator of hunger-satiety signaling, and are predisposed to a...
Saved in:
Published in | Frontiers in endocrinology (Lausanne) Vol. 16; p. 1597053 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
06.08.2025
|
Subjects | |
Online Access | Get full text |
ISSN | 1664-2392 1664-2392 |
DOI | 10.3389/fendo.2025.1597053 |
Cover
Abstract | Lipodystrophy syndromes comprise a group of rare endocrine disorders characterized by the generalized or partial loss of adipose tissue. Affected individuals frequently display absolute or relative reductions in leptin, a key adipokine regulator of hunger-satiety signaling, and are predisposed to a range of metabolic and end-organ complications, often from a young age. The presentation and severity of lipodystrophy syndromes is largely dependent on the extent of adipose tissue loss while comorbidities often deteriorate with age. In this regard, optimizing care for children and adolescents with lipodystrophy syndromes is a pivotal step in supporting them into adulthood. To assist clinicians with limited experience of managing young patients with lipodystrophy syndromes, we describe our clinical approach to a series of pediatric patients with these rare diseases.
The clinical history, diagnosis, disease management and follow-up care of 10 international pediatric patients with lipodystrophy syndromes are presented. Teaching points from each case study are also provided. Most of these cases are based on patients from our clinics with certain details changed to protect privacy. Others represent hypothetical scenarios based on our clinical experience supported by review of the medical literature and are included here for educational purposes.
Our patients illustrate the broad phenotypic spectrum of lipodystrophy syndromes that can manifest early in life. We highlight the importance of timely and accurate diagnosis in guiding early disease management strategies to help reduce the risk of comorbidities. The challenges faced by clinicians managing pediatric patients with lipodystrophy syndromes and how these challenges may differ from adult patients are also explored.
The cases presented in this manuscript may assist clinical teams to promptly diagnose and holistically manage young patients with lipodystrophy syndromes and help optimize clinical outcomes as they transition to adult care. |
---|---|
AbstractList | IntroductionLipodystrophy syndromes comprise a group of rare endocrine disorders characterized by the generalized or partial loss of adipose tissue. Affected individuals frequently display absolute or relative reductions in leptin, a key adipokine regulator of hunger-satiety signaling, and are predisposed to a range of metabolic and end-organ complications, often from a young age. The presentation and severity of lipodystrophy syndromes is largely dependent on the extent of adipose tissue loss while comorbidities often deteriorate with age. In this regard, optimizing care for children and adolescents with lipodystrophy syndromes is a pivotal step in supporting them into adulthood. To assist clinicians with limited experience of managing young patients with lipodystrophy syndromes, we describe our clinical approach to a series of pediatric patients with these rare diseases.MethodsThe clinical history, diagnosis, disease management and follow-up care of 10 international pediatric patients with lipodystrophy syndromes are presented. Teaching points from each case study are also provided. Most of these cases are based on patients from our clinics with certain details changed to protect privacy. Others represent hypothetical scenarios based on our clinical experience supported by review of the medical literature and are included here for educational purposes.ResultsOur patients illustrate the broad phenotypic spectrum of lipodystrophy syndromes that can manifest early in life. We highlight the importance of timely and accurate diagnosis in guiding early disease management strategies to help reduce the risk of comorbidities. The challenges faced by clinicians managing pediatric patients with lipodystrophy syndromes and how these challenges may differ from adult patients are also explored.DiscussionThe cases presented in this manuscript may assist clinical teams to promptly diagnose and holistically manage young patients with lipodystrophy syndromes and help optimize clinical outcomes as they transition to adult care. Lipodystrophy syndromes comprise a group of rare endocrine disorders characterized by the generalized or partial loss of adipose tissue. Affected individuals frequently display absolute or relative reductions in leptin, a key adipokine regulator of hunger-satiety signaling, and are predisposed to a range of metabolic and end-organ complications, often from a young age. The presentation and severity of lipodystrophy syndromes is largely dependent on the extent of adipose tissue loss while comorbidities often deteriorate with age. In this regard, optimizing care for children and adolescents with lipodystrophy syndromes is a pivotal step in supporting them into adulthood. To assist clinicians with limited experience of managing young patients with lipodystrophy syndromes, we describe our clinical approach to a series of pediatric patients with these rare diseases.IntroductionLipodystrophy syndromes comprise a group of rare endocrine disorders characterized by the generalized or partial loss of adipose tissue. Affected individuals frequently display absolute or relative reductions in leptin, a key adipokine regulator of hunger-satiety signaling, and are predisposed to a range of metabolic and end-organ complications, often from a young age. The presentation and severity of lipodystrophy syndromes is largely dependent on the extent of adipose tissue loss while comorbidities often deteriorate with age. In this regard, optimizing care for children and adolescents with lipodystrophy syndromes is a pivotal step in supporting them into adulthood. To assist clinicians with limited experience of managing young patients with lipodystrophy syndromes, we describe our clinical approach to a series of pediatric patients with these rare diseases.The clinical history, diagnosis, disease management and follow-up care of 10 international pediatric patients with lipodystrophy syndromes are presented. Teaching points from each case study are also provided. Most of these cases are based on patients from our clinics with certain details changed to protect privacy. Others represent hypothetical scenarios based on our clinical experience supported by review of the medical literature and are included here for educational purposes.MethodsThe clinical history, diagnosis, disease management and follow-up care of 10 international pediatric patients with lipodystrophy syndromes are presented. Teaching points from each case study are also provided. Most of these cases are based on patients from our clinics with certain details changed to protect privacy. Others represent hypothetical scenarios based on our clinical experience supported by review of the medical literature and are included here for educational purposes.Our patients illustrate the broad phenotypic spectrum of lipodystrophy syndromes that can manifest early in life. We highlight the importance of timely and accurate diagnosis in guiding early disease management strategies to help reduce the risk of comorbidities. The challenges faced by clinicians managing pediatric patients with lipodystrophy syndromes and how these challenges may differ from adult patients are also explored.ResultsOur patients illustrate the broad phenotypic spectrum of lipodystrophy syndromes that can manifest early in life. We highlight the importance of timely and accurate diagnosis in guiding early disease management strategies to help reduce the risk of comorbidities. The challenges faced by clinicians managing pediatric patients with lipodystrophy syndromes and how these challenges may differ from adult patients are also explored.The cases presented in this manuscript may assist clinical teams to promptly diagnose and holistically manage young patients with lipodystrophy syndromes and help optimize clinical outcomes as they transition to adult care.DiscussionThe cases presented in this manuscript may assist clinical teams to promptly diagnose and holistically manage young patients with lipodystrophy syndromes and help optimize clinical outcomes as they transition to adult care. Lipodystrophy syndromes comprise a group of rare endocrine disorders characterized by the generalized or partial loss of adipose tissue. Affected individuals frequently display absolute or relative reductions in leptin, a key adipokine regulator of hunger-satiety signaling, and are predisposed to a range of metabolic and end-organ complications, often from a young age. The presentation and severity of lipodystrophy syndromes is largely dependent on the extent of adipose tissue loss while comorbidities often deteriorate with age. In this regard, optimizing care for children and adolescents with lipodystrophy syndromes is a pivotal step in supporting them into adulthood. To assist clinicians with limited experience of managing young patients with lipodystrophy syndromes, we describe our clinical approach to a series of pediatric patients with these rare diseases. The clinical history, diagnosis, disease management and follow-up care of 10 international pediatric patients with lipodystrophy syndromes are presented. Teaching points from each case study are also provided. Most of these cases are based on patients from our clinics with certain details changed to protect privacy. Others represent hypothetical scenarios based on our clinical experience supported by review of the medical literature and are included here for educational purposes. Our patients illustrate the broad phenotypic spectrum of lipodystrophy syndromes that can manifest early in life. We highlight the importance of timely and accurate diagnosis in guiding early disease management strategies to help reduce the risk of comorbidities. The challenges faced by clinicians managing pediatric patients with lipodystrophy syndromes and how these challenges may differ from adult patients are also explored. The cases presented in this manuscript may assist clinical teams to promptly diagnose and holistically manage young patients with lipodystrophy syndromes and help optimize clinical outcomes as they transition to adult care. |
Author | Cappa, Marco Williams, Rachel Wabitsch, Martin Musso, Carla Patni, Nivedita Prodam, Flavia Akinci, Baris Brown, Rebecca J. Bismuth, Elise Deeb, Asma Al Yaarubi, Saif Kamrath, Clemens |
AuthorAffiliation | 3 Oman Medical Specialty Board , Muscat , Oman 4 Department of Pediatric Endocrinology, Assistance Publique-Hôpitaux de Paris, Robert Debré Hospital , Paris , France 9 Division of Pediatric Endocrinology, Department of Pediatrics, University of Texas (UT) Southwestern Medical Center , Dallas, TX , United States 6 Division of Paediatric Endocrine, Sheikh Shakhbout Medical City and College of Medicine and Health Sciences, Khalifa University , Abu Dhabi , United Arab Emirates 11 Cambridge University Hospitals, National Health Service (NHS) Foundation Trust , Cambridge , United Kingdom 10 Unit of Endocrinology, Department of Health Sciences, University of Eastern Piedmont , Novara , Italy 1 National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD , United States 5 Research Unit for Innovative Therapies in Endocrinopathies, Bambino Gesù Children’s Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) , Rome , Italy 8 Hosp |
AuthorAffiliation_xml | – name: 12 Nottingham Children’s Hospital , Nottingham , United Kingdom – name: 3 Oman Medical Specialty Board , Muscat , Oman – name: 13 German Center for Child and Adolescent Health (DZKJ), Ulm Site, Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, University Medical Center , Ulm , Germany – name: 6 Division of Paediatric Endocrine, Sheikh Shakhbout Medical City and College of Medicine and Health Sciences, Khalifa University , Abu Dhabi , United Arab Emirates – name: 4 Department of Pediatric Endocrinology, Assistance Publique-Hôpitaux de Paris, Robert Debré Hospital , Paris , France – name: 7 Centre of Child and Adolescent Medicine, Department of General Pediatrics and Neonatology, University Hospital Freiburg , Freiburg , Germany – name: 9 Division of Pediatric Endocrinology, Department of Pediatrics, University of Texas (UT) Southwestern Medical Center , Dallas, TX , United States – name: 10 Unit of Endocrinology, Department of Health Sciences, University of Eastern Piedmont , Novara , Italy – name: 11 Cambridge University Hospitals, National Health Service (NHS) Foundation Trust , Cambridge , United Kingdom – name: 1 National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD , United States – name: 8 Hospital Universitario Fundación Favaloro , Ciudad Autónoma de Buenos Aires , Argentina – name: 2 Department of Technological Research, Izmir Biomedicine and Genome Center, Dokuz Eylül University , Izmir , Türkiye – name: 5 Research Unit for Innovative Therapies in Endocrinopathies, Bambino Gesù Children’s Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) , Rome , Italy |
Author_xml | – sequence: 1 givenname: Rebecca J. surname: Brown fullname: Brown, Rebecca J. – sequence: 2 givenname: Baris surname: Akinci fullname: Akinci, Baris – sequence: 3 givenname: Saif surname: Al Yaarubi fullname: Al Yaarubi, Saif – sequence: 4 givenname: Elise surname: Bismuth fullname: Bismuth, Elise – sequence: 5 givenname: Marco surname: Cappa fullname: Cappa, Marco – sequence: 6 givenname: Asma surname: Deeb fullname: Deeb, Asma – sequence: 7 givenname: Clemens surname: Kamrath fullname: Kamrath, Clemens – sequence: 8 givenname: Carla surname: Musso fullname: Musso, Carla – sequence: 9 givenname: Nivedita surname: Patni fullname: Patni, Nivedita – sequence: 10 givenname: Flavia surname: Prodam fullname: Prodam, Flavia – sequence: 11 givenname: Rachel surname: Williams fullname: Williams, Rachel – sequence: 12 givenname: Martin surname: Wabitsch fullname: Wabitsch, Martin |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40842493$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkstqHDEQRUVwiB_xD2QRtMxmJnp2t7IJwSSxwZCNsxZ6lNwyGqkj9cTM36fHMzG2QFRRupwLpXuOTnLJgNAHStacD-pzgOzLmhEm11Sqnkj-Bp3RrhMrxhU7edGfosvWHshyBKFKDe_QqSCDYELxM7S9GwG7FHN0JmEzTbUYN-K5YDfG5LHJy_UlQXOQZzyZOS614cc4jzjFqfhdm2uZxt0XbHCDGqHhEnDMM9S8qEteuM40wD42t21tmbT36G0wqcHlsV6g3z--311dr25__by5-na7coKxecWHAJJaIMC6YJ2RvWKB9CQYS23og1LES6Z6ykLwUhAlOBkY81I5q0Kn-AW6OXB9MQ96qnFj6k4XE_XToNR7beocXQItwHYWVAAqgxDcWSt4NxBnXVBO9nJhfT2wpq3dgN-vo5r0Cvr6JcdR35e_mjLedZSQhfDpSKjlzxbarDfLSiAlk6Fsm-ZMdJwwxfZmH1-aPbv8_7hFwA4CV0trFcKzhBK9D4h-CojeB0QfA8L_AQEese8 |
Cites_doi | 10.1210/clinem/dgae335 10.1126/scitranslmed.add4897 10.1186/s40842-018-0058-3 10.1016/j.cjca.2014.09.007 10.1186/s13023-019-1141-2 10.1111/cge.12623 10.1371/journal.pone.0162513 10.1210/jc.2003-031868 10.1016/j.medj.2021.04.001 10.1210/jc.2016-1005 10.1210/jc.2007-1328 10.1002/ajmg.a.63533 10.1186/s13052-020-00916-2 10.1016/j.seizure.2016.08.008 10.1097/01.md.0000111061.69212.59 10.1186/s13023-024-03173-2 10.1210/jc.2016-2466 10.1371/journal.pgen.1000874 10.1097/00005792-200303000-00007 10.1002/emmm.200900037 10.1016/j.cell.2007.11.042 10.1056/NEJMoa012437 10.1210/jc.2018-02730 10.1210/js.2019-00103 10.4274/jcrpe.galenos.2019.2019.0124 10.1016/j.molmet.2013.07.001 10.1210/jendso/bvad114.069 10.1056/nejmc2413871 10.1016/j.mrrev.2019.03.005 10.1016/j.ecl.2020.02.008 10.1210/clinem/dgab499 10.1016/j.beem.2007.04.007 10.1186/s13023-024-03084-2 10.1038/47254 10.3389/fendo.2021.803189 10.1016/S0140-6736(46)91599-1 10.1007/s40265-013-0074-7 10.1056/nejmoa1315496 10.1038/ng585 10.1111/j.1651-2227.1959.tb16421.x 10.1210/jc.84.9.3390 10.3389/fendo.2023.1250203 10.1038/ng0398-292 10.1007/BF02867054 10.1016/j.metabol.2004.08.021 10.1210/jc.75.2.358 10.2337/db24-0624 10.1210/jc.87.5.2395 10.1210/clinem/dgab216 10.2337/dc23-1614 10.1016/j.ecl.2017.01.012 10.1530/eje-12-0268 10.1093/hmg/9.1.109 10.1038/s41598-023-27987-5 10.1172/jci38660 10.1210/jc.2016-3628 10.1242/dmm.042655 10.1210/jcem-14-2-193 10.1080/17446651.2020.1735360 10.1002/ajmg.a.37115 10.4158/endp.19.1.v767575m65p5mr06 10.1210/jcem.87.1.8290 10.1038/72807 10.1186/s13023-024-03245-3 10.1111/dom.15061 10.1111/dom.16175 10.1210/clinem/dgaf103 10.1056/nejmra025261 10.2337/dbi24-0018 10.1002/ajmg.a.33578 10.1210/clinem/dgad700 10.1136/jmedgenet-2013-101525 10.1210/jendso/bvab048.594 10.1210/jc.2011-1159 10.1210/jc.2017-02078 10.3389/fimmu.2018.02142 10.3389/fendo.2024.1383318 10.2337/db21-1086 10.1056/nejmoa1007487 10.1038/ng880 10.1210/jc.2016-2271 10.1210/jendso/bvab019 10.1210/jc.2019-00200 10.2147/DMSO.S130810 10.2337/dc24-2408 10.1016/j.eprac.2022.03.006 10.1007/s10048-019-00574-5 10.1038/ng.3714 10.1038/s42255-019-0095-y 10.1136/jmg.23.2.120 10.1007/s40618-018-0887-z 10.1186/s13023-020-01364-1 |
ContentType | Journal Article |
Copyright | Copyright © 2025 Brown, Akinci, Al Yaarubi, Bismuth, Cappa, Deeb, Kamrath, Musso, Patni, Prodam, Williams and Wabitsch. Copyright © 2025 Brown, Akinci, Al Yaarubi, Bismuth, Cappa, Deeb, Kamrath, Musso, Patni, Prodam, Williams and Wabitsch. 2025 Brown, Akinci, Al Yaarubi, Bismuth, Cappa, Deeb, Kamrath, Musso, Patni, Prodam, Williams and Wabitsch |
Copyright_xml | – notice: Copyright © 2025 Brown, Akinci, Al Yaarubi, Bismuth, Cappa, Deeb, Kamrath, Musso, Patni, Prodam, Williams and Wabitsch. – notice: Copyright © 2025 Brown, Akinci, Al Yaarubi, Bismuth, Cappa, Deeb, Kamrath, Musso, Patni, Prodam, Williams and Wabitsch. 2025 Brown, Akinci, Al Yaarubi, Bismuth, Cappa, Deeb, Kamrath, Musso, Patni, Prodam, Williams and Wabitsch |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
DOI | 10.3389/fendo.2025.1597053 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ (Directory of Open Access Journals) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1664-2392 |
ExternalDocumentID | oai_doaj_org_article_4eb6be9fe15f443cbb43680cbcf9c575 PMC12366100 40842493 10_3389_fendo_2025_1597053 |
Genre | Journal Article Review Case Reports |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EMOBN GROUPED_DOAJ GX1 HYE KQ8 M~E OK1 PGMZT RPM CGR CUY CVF ECM EIF IPNFZ M48 NPM RIG 7X8 5PM |
ID | FETCH-LOGICAL-c422t-38fe51be0e26fbca5792f070fab1bf7f990d529712ffd5409430822d59cb9f693 |
IEDL.DBID | DOA |
ISSN | 1664-2392 |
IngestDate | Wed Aug 27 01:28:27 EDT 2025 Sat Aug 23 05:22:14 EDT 2025 Thu Sep 04 12:30:46 EDT 2025 Thu Sep 04 05:01:47 EDT 2025 Thu Aug 14 00:10:49 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | acquired generalized lipodystrophy comorbidities congenital generalized lipodystrophy metreleptin adolescent familial partial lipodystrophy acquired partial lipodystrophy pediatric |
Language | English |
License | Copyright © 2025 Brown, Akinci, Al Yaarubi, Bismuth, Cappa, Deeb, Kamrath, Musso, Patni, Prodam, Williams and Wabitsch. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c422t-38fe51be0e26fbca5792f070fab1bf7f990d529712ffd5409430822d59cb9f693 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Review-5 content type line 23 ObjectType-Case Study-4 ObjectType-Feature-2 ObjectType-Report-3 Víctor A. Cortés, Pontificia Universidad Católica de Chile, Chile ORCID: Asma Deeb, orcid.org/0000-0003-4090-4672; Nivedita Patni, orcid.org/0000-0002-5926-7784; Flavia Prodam, orcid.org/0000-0001-9660-5335; Martin Wabitsch, orcid.org/0000-0001-6795-8430 Reviewed by: Alexander Bartelt, Ludwig Maximilian University of Munich, Germany Toru Kusakabe, National Hospital Organization Kyoto Medical Center, Japan Edited by: Artur Mazur, University of Rzeszow, Poland |
OpenAccessLink | https://doaj.org/article/4eb6be9fe15f443cbb43680cbcf9c575 |
PMID | 40842493 |
PQID | 3246302925 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_4eb6be9fe15f443cbb43680cbcf9c575 pubmedcentral_primary_oai_pubmedcentral_nih_gov_12366100 proquest_miscellaneous_3246302925 pubmed_primary_40842493 crossref_primary_10_3389_fendo_2025_1597053 |
PublicationCentury | 2000 |
PublicationDate | 2025-08-06 |
PublicationDateYYYYMMDD | 2025-08-06 |
PublicationDate_xml | – month: 08 year: 2025 text: 2025-08-06 day: 06 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in endocrinology (Lausanne) |
PublicationTitleAlternate | Front Endocrinol (Lausanne) |
PublicationYear | 2025 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Friedman (B51) 2019; 1 Taniguchi (B77) 2016; 11 Rajab (B22) 2010; 6 Araujo-Vilar (B86) 2020; 15 Chou (B55) 2013; 73 Hussain (B68) 2018; 103 Barraquer (B4) 1907; 26 Corvillo (B41) 2018; 9 Garg (B103) 2025; 74 Simons (B10) 1911; 5 Araujo-Vilar (B14) 2019; 42 Akinci (B13) 2024; 73 Brown (B88) 2025 Farhan (B34) 2014; 30 McDuffie (B64) 2004; 89 Agarwal (B25) 2002; 87 Sánchez-Iglesias (B81) 2019; 20 Kobberling (B7) 1986; 23 Lamothe (B73) 2025 Garg (B2) 2004; 350 Seip (B9) 1959; 48 Wells (B85) 2007; 21 Garg (B18) 2015 Corvillo (B40) 2023; 72 Foss-Freitas (B72) 2024; 47 Meral (B75) 2025; 48 Chiquette (B12) 2017; 10 Altarejos (B101) 2023; 15 Haque (B48) 2002; 87 Lotta (B33) 2017; 49 Brown (B61) 2017; 102 Guillén-Navarro (B82) 2013; 50 Magre (B21) 2001; 28 Lightbourne (B63) 2021; 5 Bansal (B71) 2022; 28 Cao (B28) 2000; 9 Vatier (B95) 2019; 14 Shackleton (B31) 2000; 24 B54 B56 B57 B58 Misra (B39) 2003; 82 B59 Berardinelli (B5) 1954; 14 Donadille (B62) 2024; 19 Gavin (B84) 2020; 49 Peters (B35) 1998; 18 B100 Yildirim Simsir (B47) 2023; 25 Misra (B38) 2004; 83 Agarwal (B15) 2002; 31 Cook (B89) 2021; 5 B60 McIlroy (B78) 2020; 13 Ozen (B97) 2020; 12 Dunnigan (B6) 1974; 43 Garg (B11) 2011; 96 Blüher (B83) 2013; 2 Gandotra (B29) 2011; 364 Lightbourne (B30) 2017; 46 Cook (B90) 2021; 106 (B99) 2025 Sahinoz (B79) 2018; 4 Gupta (B46) 2017; 102 Hill (B76) 2008; 132 Lawrence (B8) 1946; 1 Akinci (B96) 2021; 2 Opri (B80) 2016; 42 Albert (B26) 2014; 370 Foss-Freitas (B37) 2020; 15 Mory (B67) 2012; 167 Akinci (B43) 2019; 104 Brown (B1) 2016; 101 Garg (B17) 1992; 75 Craveiro Sarmento (B16) 2019; 781 Oral (B49) 2002; 346 Musso (B93) 2005; 54 Lee (B92) 2019; 104 Barroso (B27) 1999; 402 Fernandez-Pombo (B45) 2023; 14 Zammouri (B53) 2021; 12 Akinci (B32) 2000 Nguyen (B94) 2021; 106 Brush (B66) 2024; 110 da Cunha Olegario (B87) 2023; 13 Rubio-Cabezas (B36) 2009; 1 Patni (B98) 2024; 19 Kim (B20) 2008; 93 Al Yaarubi (B44) 2024; 19 Kinzer (B91) 2019; 3 Garg (B19) 1999; 84 Shastry (B23) 2010 Ten (B74) 2025; 392 Akinci (B50) 2016; 101 Pedicelli (B70) 2020; 46 Olenchock (B102) 2023; 7 Fourman (B52) 2024; 15 Hayashi (B24) 2009; 119 Akinci (B65) 2024; 194 Haghighi (B69) 2016; 89 Magno (B42) 2024; 109 Handelsman (B3) 2013; 19 |
References_xml | – volume: 110 year: 2024 ident: B66 article-title: Effects of metreleptin in patients with generalized lipodystrophy before vs after the onset of severe metabolic disease publication-title: J Clin Endocrinol Metab doi: 10.1210/clinem/dgae335 – volume: 15 year: 2023 ident: B101 article-title: Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiency publication-title: Sci Transl Med doi: 10.1126/scitranslmed.add4897 – volume: 4 start-page: 6 year: 2018 ident: B79 article-title: Potential association of LMNA-associated generalized lipodystrophy with juvenile dermatomyositis publication-title: Clin Diabetes Endocrinol doi: 10.1186/s40842-018-0058-3 – volume: 30 year: 2014 ident: B34 article-title: A novel LIPE nonsense mutation found using exome sequencing in siblings with late-onset familial partial lipodystrophy publication-title: Can J Cardiol doi: 10.1016/j.cjca.2014.09.007 – volume: 14 start-page: 177 year: 2019 ident: B95 article-title: Adherence with metreleptin therapy and health self-perception in patients with lipodystrophic syndromes publication-title: Orphanet J Rare Dis doi: 10.1186/s13023-019-1141-2 – volume: 89 year: 2016 ident: B69 article-title: Congenital generalized lipodystrophy: identification of novel variants and expansion of clinical spectrum publication-title: Clin Genet doi: 10.1111/cge.12623 – volume: 11 start-page: e0162513 year: 2016 ident: B77 article-title: PTRF/cavin-1 deficiency causes cardiac dysfunction accompanied by cardiomyocyte hypertrophy and cardiac fibrosis publication-title: PloS One doi: 10.1371/journal.pone.0162513 – volume: 89 year: 2004 ident: B64 article-title: Effects of exogenous leptin on satiety and satiation in patients with lipodystrophy and leptin insufficiency publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2003-031868 – volume: 2 year: 2021 ident: B96 article-title: Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings publication-title: Med doi: 10.1016/j.medj.2021.04.001 – volume: 101 year: 2016 ident: B50 article-title: Natural history of congenital generalized lipodystrophy: A nationwide study from Turkey publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2016-1005 – volume: 93 year: 2008 ident: B20 article-title: Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2007-1328 – ident: B58 – volume: 194 start-page: e63533 year: 2024 ident: B65 article-title: Metabolic and other morbid complications in congenital generalized lipodystrophy type 4 publication-title: Am J Med Genet A doi: 10.1002/ajmg.a.63533 – volume: 46 start-page: 158 year: 2020 ident: B70 article-title: Metreleptin for the treatment of progressive encephalopathy with/without lipodystrophy (PELD) in a child with progressive myoclonic epilepsy: a case report publication-title: Ital J Pediatr doi: 10.1186/s13052-020-00916-2 – volume: 43 start-page: 33 year: 1974 ident: B6 article-title: Familial lipoatrophic diabetes with dominant transmission. A new syndrome publication-title: Q J Med – volume: 42 start-page: 1 year: 2016 ident: B80 article-title: Progressive Myoclonus Epilepsy in Congenital Generalized Lipodystrophy type 2: Report of 3 cases and literature review publication-title: Seizure doi: 10.1016/j.seizure.2016.08.008 – volume: 83 start-page: 18 year: 2004 ident: B38 article-title: Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature publication-title: Med (Baltimore) doi: 10.1097/01.md.0000111061.69212.59 – volume: 19 start-page: 177 year: 2024 ident: B62 article-title: Diagnostic and referral pathways in patients with rare lipodystrophy and insulin-resistance syndromes: key milestones assessed from a national reference center publication-title: Orphanet J Rare Dis doi: 10.1186/s13023-024-03173-2 – volume: 101 year: 2016 ident: B1 article-title: The diagnosis and management of lipodystrophy syndromes: A multi-society practice guideline publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2016-2466 – volume: 6 start-page: e1000874 year: 2010 ident: B22 article-title: Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations publication-title: PloS Genet doi: 10.1371/journal.pgen.1000874 – volume: 82 year: 2003 ident: B39 article-title: Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature publication-title: Med (Baltimore) doi: 10.1097/00005792-200303000-00007 – volume: 1 year: 2009 ident: B36 article-title: Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC publication-title: EMBO Mol Med doi: 10.1002/emmm.200900037 – volume: 132 year: 2008 ident: B76 article-title: PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function publication-title: Cell doi: 10.1016/j.cell.2007.11.042 – volume: 346 year: 2002 ident: B49 article-title: Leptin-replacement therapy for lipodystrophy publication-title: N Engl J Med doi: 10.1056/NEJMoa012437 – volume: 104 year: 2019 ident: B43 article-title: Comorbidities and survival in patients with lipodystrophy: an international chart review study publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2018-02730 – volume: 3 year: 2019 ident: B91 article-title: Advanced lipoprotein analysis shows atherogenic lipid profile that improves after metreleptin in patients with lipodystrophy publication-title: J Endocr Soc doi: 10.1210/js.2019-00103 – volume: 12 start-page: 17 year: 2020 ident: B97 article-title: Current diagnosis, treatment and clinical challenges in the management of lipodystrophy syndromes in children and young people publication-title: J Clin Res Pediatr Endocrinol doi: 10.4274/jcrpe.galenos.2019.2019.0124 – volume: 2 year: 2013 ident: B83 article-title: Importance of estrogen receptors in adipose tissue function publication-title: Mol Metab doi: 10.1016/j.molmet.2013.07.001 – volume: 7 year: 2023 ident: B102 article-title: FRI058 treatment with mibavademab, A novel leptin receptor agonist, is associated with improvement in metabolic parameters in individuals with generalized lipodystrophy publication-title: J Endocrine Soc doi: 10.1210/jendso/bvad114.069 – volume: 392 year: 2025 ident: B74 article-title: Tirzepatide for congenital generalized lipodystrophy publication-title: N Engl J Med doi: 10.1056/nejmc2413871 – volume: 781 start-page: 30 year: 2019 ident: B16 article-title: The worldwide mutational landscape of Berardinelli-Seip congenital lipodystrophy publication-title: Mutat Res Rev Mutat Res doi: 10.1016/j.mrrev.2019.03.005 – volume: 49 year: 2020 ident: B84 article-title: Sex differences in adipose tissue function publication-title: Endocrinol Metab Clin North Am doi: 10.1016/j.ecl.2020.02.008 – volume: 106 year: 2021 ident: B94 article-title: Leptin attenuates cardiac hypertrophy in patients with generalized lipodystrophy publication-title: J Clin Endocrinol Metab doi: 10.1210/clinem/dgab499 – volume: 21 year: 2007 ident: B85 article-title: Sexual dimorphism of body composition publication-title: Best Pract Res Clin Endocrinol Metab doi: 10.1016/j.beem.2007.04.007 – volume: 19 start-page: 118 year: 2024 ident: B44 article-title: Analysis of disease characteristics of a large patient cohort with congenital generalized lipodystrophy from the Middle East and North Africa publication-title: Orphanet J Rare Dis doi: 10.1186/s13023-024-03084-2 – volume: 402 year: 1999 ident: B27 article-title: Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension publication-title: Nature doi: 10.1038/47254 – volume: 12 year: 2021 ident: B53 article-title: Molecular and cellular bases of lipodystrophy syndromes publication-title: Front Endocrinol (Lausanne) doi: 10.3389/fendo.2021.803189 – volume: 1 start-page: 773 year: 1946 ident: B8 article-title: Lipodystrophy and hepatomegaly with diabetes, lipaemia, and other metabolic disturbances; a case throwing new light on the action of insulin. (concluded) publication-title: Lancet doi: 10.1016/S0140-6736(46)91599-1 – volume: 73 year: 2013 ident: B55 article-title: Metreleptin: first global approval publication-title: Drugs doi: 10.1007/s40265-013-0074-7 – volume: 370 year: 2014 ident: B26 article-title: Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes publication-title: N Engl J Med doi: 10.1056/nejmoa1315496 – volume: 28 year: 2001 ident: B21 article-title: Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13 publication-title: Nat Genet doi: 10.1038/ng585 – volume: 48 year: 1959 ident: B9 article-title: Lipodystrophy and gigantism with associated endocrine manifestations. A new diencephalic syndrome publication-title: Acta Paediatr (Stockh) doi: 10.1111/j.1651-2227.1959.tb16421.x – volume: 84 year: 1999 ident: B19 article-title: A gene for congenital generalized lipodystrophy maps to human chromosome 9q34 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.84.9.3390 – volume: 14 year: 2023 ident: B45 article-title: Natural history and comorbidities of generalised and partial lipodystrophy syndromes in Spain publication-title: Front Endocrinol (Lausanne) doi: 10.3389/fendo.2023.1250203 – volume: 18 year: 1998 ident: B35 article-title: Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22 publication-title: Nat Genet doi: 10.1038/ng0398-292 – volume: 5 start-page: 29 year: 1911 ident: B10 article-title: Lipodystrophia progressiva publication-title: Z ges Neurol Psychiat doi: 10.1007/BF02867054 – volume: 54 year: 2005 ident: B93 article-title: The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients publication-title: Metabolism doi: 10.1016/j.metabol.2004.08.021 – volume: 75 year: 1992 ident: B17 article-title: Peculiar distribution of adipose tissue in patients with congenital generalized lipodystrophy publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.75.2.358 – volume: 74 year: 2025 ident: B103 article-title: Gain of function NOTCH3 variants cause familial partial lipodystrophy due to activation of senescence pathways publication-title: Diabetes doi: 10.2337/db24-0624 – volume: 87 start-page: 2395 year: 2002 ident: B48 article-title: Serum adiponectin and leptin levels in patients with lipodystrophies publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.87.5.2395 – volume: 106 year: 2021 ident: B90 article-title: Effect of leptin therapy on survival in generalized and partial lipodystrophy: A matched cohort analysis publication-title: J Clin Endocrinol Metab doi: 10.1210/clinem/dgab216 – ident: B57 – volume: 47 year: 2024 ident: B72 article-title: Efficacy and safety of glucagon-like peptide 1 agonists in a retrospective study of patients with familial partial lipodystrophy publication-title: Diabetes Care doi: 10.2337/dc23-1614 – volume: 46 year: 2017 ident: B30 article-title: Genetics of lipodystrophy publication-title: Endocrinol Metab Clin North Am doi: 10.1016/j.ecl.2017.01.012 – ident: B60 – volume: 167 year: 2012 ident: B67 article-title: Phenotypic diversity in patients with lipodystrophy associated with LMNA mutations publication-title: Eur J Endocrinol doi: 10.1530/eje-12-0268 – volume: 26 start-page: 1072 year: 1907 ident: B4 article-title: Histoire clinique d’un cas d’atrophie du tissu celluloadipeux publication-title: Neurolog Zentralblatt – volume: 9 year: 2000 ident: B28 article-title: Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy publication-title: Hum Mol Genet doi: 10.1093/hmg/9.1.109 – volume: 13 start-page: 2176 year: 2023 ident: B87 article-title: Identifying congenital generalized lipodystrophy using deep learning-DEEPLIPO publication-title: Sci Rep doi: 10.1038/s41598-023-27987-5 – volume: 119 year: 2009 ident: B24 article-title: Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy publication-title: J Clin Invest doi: 10.1172/jci38660 – volume: 102 year: 2017 ident: B61 article-title: Effects of metreleptin in pediatric patients with lipodystrophy publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2016-3628 – volume: 13 year: 2020 ident: B78 article-title: Ablation of Bscl2/seipin in hepatocytes does not cause metabolic dysfunction in congenital generalised lipodystrophy publication-title: Dis Model Mech doi: 10.1242/dmm.042655 – volume: 14 start-page: 193 year: 1954 ident: B5 article-title: An undiagnosed endocrinometabolic syndrome: report of 2 cases publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem-14-2-193 – volume: 15 start-page: 95 year: 2020 ident: B37 article-title: Diagnostic strategies and clinical management of lipodystrophy publication-title: Expert Rev Endocrinol Metab doi: 10.1080/17446651.2020.1735360 – ident: B54 – ident: B59 – year: 2015 ident: B18 article-title: Whole exome sequencing identifies de novo heterozygous CAV1 mutations associated with a novel neonatal onset lipodystrophy syndrome publication-title: Am J Med Genet A doi: 10.1002/ajmg.a.37115 – volume: 19 year: 2013 ident: B3 article-title: The clinical approach to the detection of lipodystrophy - an AACE consensus statement publication-title: Endocr Pract doi: 10.4158/endp.19.1.v767575m65p5mr06 – volume: 87 year: 2002 ident: B25 article-title: A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem.87.1.8290 – volume: 24 year: 2000 ident: B31 article-title: LMNA, encoding lamin A/C, is mutated in partial lipodystrophy publication-title: Nat Genet doi: 10.1038/72807 – volume: 19 start-page: 263 year: 2024 ident: B98 article-title: Diagnosis, treatment and management of lipodystrophy: the physician perspective on the patient journey publication-title: Orphanet J Rare Dis doi: 10.1186/s13023-024-03245-3 – volume: 25 year: 2023 ident: B47 article-title: Clinical features of generalized lipodystrophy in Turkey: A cohort analysis publication-title: Diabetes Obes Metab doi: 10.1111/dom.15061 – year: 2025 ident: B73 article-title: Safety and effectiveness in an uncontrolled setting of glucagon-like-peptide-1 receptor agonists in patients with familial partial lipodystrophy: Real-life experience from a national reference network publication-title: Diabetes Obes Metab doi: 10.1111/dom.16175 – year: 2025 ident: B88 article-title: Lipodystrophy severity score to assess disease burden in lipodystrophy publication-title: J Clin Endocrinol Metab doi: 10.1210/clinem/dgaf103 – volume: 350 year: 2004 ident: B2 article-title: Acquired and inherited lipodystrophies publication-title: N Engl J Med doi: 10.1056/nejmra025261 – volume: 73 year: 2024 ident: B13 article-title: Lipodystrophy prevalence, “Lipodystrophy-like phenotypes,” and diagnostic challenges publication-title: Diabetes doi: 10.2337/dbi24-0018 – year: 2010 ident: B23 article-title: Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations publication-title: Am J Med Genet A doi: 10.1002/ajmg.a.33578 – volume: 109 year: 2024 ident: B42 article-title: Clinical characteristics of patients with acquired partial lipodystrophy: A multicenter retrospective study publication-title: J Clin Endocrinol Metab doi: 10.1210/clinem/dgad700 – volume: 50 year: 2013 ident: B82 article-title: A new seipin-associated neurodegenerative syndrome publication-title: J Med Genet doi: 10.1136/jmedgenet-2013-101525 – volume: 5 start-page: A292 year: 2021 ident: B63 article-title: Long term effects of leptin on hepatic fibrosis in generalized lipodystrophy publication-title: J Endocr Soc doi: 10.1210/jendso/bvab048.594 – volume: 96 year: 2011 ident: B11 article-title: Clinical review: Lipodystrophies: genetic and acquired body fat disorders publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2011-1159 – ident: B100 – volume: 103 year: 2018 ident: B68 article-title: A novel generalized lipodystrophy-associated progeroid syndrome due to recurrent heterozygous LMNA p.T10I mutation publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2017-02078 – volume: 9 year: 2018 ident: B41 article-title: Autoantibodies against perilipin 1 as a cause of acquired generalized lipodystrophy publication-title: Front Immunol doi: 10.3389/fimmu.2018.02142 – volume: 15 year: 2024 ident: B52 article-title: A rapid action plan to improve diagnosis and management of lipodystrophy syndromes publication-title: Front Endocrinol (Lausanne) doi: 10.3389/fendo.2024.1383318 – ident: B56 – volume: 72 start-page: 71 year: 2023 ident: B40 article-title: Characterization and clinical association of autoantibodies against perilipin 1 in patients with acquired generalized lipodystrophy publication-title: Diabetes doi: 10.2337/db21-1086 – volume: 364 year: 2011 ident: B29 article-title: Perilipin deficiency and autosomal dominant partial lipodystrophy publication-title: N Engl J Med doi: 10.1056/nejmoa1007487 – volume: 31 year: 2002 ident: B15 article-title: AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34 publication-title: Nat Genet doi: 10.1038/ng880 – volume: 102 year: 2017 ident: B46 article-title: Clinical features and management of non-HIV-related lipodystrophy in children: A systematic review publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2016-2271 – volume: 5 start-page: bvab019 year: 2021 ident: B89 article-title: Effects of metreleptin on patient outcomes and quality of life in generalized and partial lipodystrophy publication-title: J Endocr Soc doi: 10.1210/jendso/bvab019 – volume: 104 year: 2019 ident: B92 article-title: Effects of metreleptin on proteinuria in patients with lipodystrophy publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2019-00200 – year: 2025 ident: B99 article-title: Prescribing Information – volume: 10 year: 2017 ident: B12 article-title: Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges publication-title: Diabetes Metab Syndr Obes doi: 10.2147/DMSO.S130810 – volume-title: Lipodystrophy syndromes: presentation and treatment year: 2000 ident: B32 – volume: 48 year: 2025 ident: B75 article-title: Metabolic improvements with tirzepatide in lipodystrophy: A novel option publication-title: Diabetes Care doi: 10.2337/dc24-2408 – volume: 28 year: 2022 ident: B71 article-title: Clinical effects of sodium-glucose transporter type 2 inhibitors in patients with partial lipodystrophy publication-title: Endocr Pract doi: 10.1016/j.eprac.2022.03.006 – volume: 20 start-page: 73 year: 2019 ident: B81 article-title: Celia’s encephalopathy and c.974dupG in BSCL2 gene: a hidden change in a known variant publication-title: Neurogenetics doi: 10.1007/s10048-019-00574-5 – volume: 49 start-page: 17 year: 2017 ident: B33 article-title: Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance publication-title: Nat Genet doi: 10.1038/ng.3714 – volume: 1 year: 2019 ident: B51 article-title: Leptin and the endocrine control of energy balance publication-title: Nat Metab doi: 10.1038/s42255-019-0095-y – volume: 23 year: 1986 ident: B7 article-title: Familial partial lipodystrophy: two types of an X linked dominant syndrome, lethal in the hemizygous state publication-title: J Med Genet doi: 10.1136/jmg.23.2.120 – volume: 42 start-page: 61 year: 2019 ident: B14 article-title: Diagnosis and treatment of lipodystrophy: a step-by-step approach publication-title: J Endocrinol Invest doi: 10.1007/s40618-018-0887-z – volume: 15 start-page: 81 year: 2020 ident: B86 article-title: LipoDDx: a mobile application for identification of rare lipodystrophy syndromes publication-title: Orphanet J Rare Dis doi: 10.1186/s13023-020-01364-1 |
SSID | ssj0000401998 |
Score | 2.378782 |
SecondaryResourceType | review_article |
Snippet | Lipodystrophy syndromes comprise a group of rare endocrine disorders characterized by the generalized or partial loss of adipose tissue. Affected individuals... IntroductionLipodystrophy syndromes comprise a group of rare endocrine disorders characterized by the generalized or partial loss of adipose tissue. Affected... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 1597053 |
SubjectTerms | acquired generalized lipodystrophy acquired partial lipodystrophy Adolescent Child Child, Preschool comorbidities congenital generalized lipodystrophy Endocrinology familial partial lipodystrophy Female Humans Lipodystrophy - diagnosis Lipodystrophy - therapy Male pediatric |
Title | The clinical approach to child and adolescent patients with lipodystrophy: a series of international case discussions |
URI | https://www.ncbi.nlm.nih.gov/pubmed/40842493 https://www.proquest.com/docview/3246302925 https://pubmed.ncbi.nlm.nih.gov/PMC12366100 https://doaj.org/article/4eb6be9fe15f443cbb43680cbcf9c575 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlh9BLaJIm2bxQoLfiRJYl28otCdksgfbUwN6EnnSh2CH2HvrvOyN7l90S6KUH-2DLeNA30sxIM58I-VLAmOFB1JkVuFoFViEz0pks93UEC8NM7VO2xfdy9iKe53K-cdQX5oQN9MBDx92IYEsbVAy5jEIUzlrkTGfOuqgc-Bo4-zLFNoKpNAdD2ACBxFAlA1GYuomh8Vjsx-U1WPCKyWLLEiXC_ve8zL-TJTesz_QT2RvdRno3iLtPPoTmgOx-GzfGD8kS4KarKke6IgqnfUtTtTY1DVxr8iY6sql2FJdh6a_Fa-t_d_1bC31-Sw1FtQwdbSNdbC4YUgcmj2Id7xJzZ5vuM3mZPv54mGXjiQqZE5z3WVHHIHMbWOBltM7ISvEIgz4am9tYRTBNXnJV5TxGLzH0QzYb7qVyVsVSFUdkp2mbcEJoWUcDzh7uggYBgBguuYePlHemKryakK-r3tWvA3GGhoADsdAJC41Y6BGLCblHANYtkfQ6PQBV0KMq6H-pwoRcreDTMEhw58M0oV12GrzGsmBccWhzPMC5_pVgtYAYFESot4DekmX7TbP4mYi4kbkG3E92-j-kPyMfsUdScmF5Tnb6t2W4AIent5dJt-H-NM__AB-qA74 |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+clinical+approach+to+child+and+adolescent+patients+with+lipodystrophy%3A+a+series+of+international+case+discussions&rft.jtitle=Frontiers+in+endocrinology+%28Lausanne%29&rft.au=Brown%2C+Rebecca+J&rft.au=Akinci%2C+Baris&rft.au=Al+Yaarubi%2C+Saif&rft.au=Bismuth%2C+Elise&rft.date=2025-08-06&rft.issn=1664-2392&rft.eissn=1664-2392&rft.volume=16&rft.spage=1597053&rft_id=info:doi/10.3389%2Ffendo.2025.1597053&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-2392&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-2392&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-2392&client=summon |